IN2014DN08588A - - Google Patents

Info

Publication number
IN2014DN08588A
IN2014DN08588A IN8588DEN2014A IN2014DN08588A IN 2014DN08588 A IN2014DN08588 A IN 2014DN08588A IN 8588DEN2014 A IN8588DEN2014 A IN 8588DEN2014A IN 2014DN08588 A IN2014DN08588 A IN 2014DN08588A
Authority
IN
India
Prior art keywords
1himidazol
benzenamine
trifluoromethyl
safe
prepare
Prior art date
Application number
Inventor
Stephan Abel
Murat Acemoglu
Bernhard Erb
Christoph Krell
Joseph Sclafani
Mark Meisenbach
Mahavir Prashad
Wen-Chung Shieh
Song Xue
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN08588(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IN2014DN08588A publication Critical patent/IN2014DN08588A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention provides an efficient, safe and cost effective way to prepare 5-(4-methyl-1Himidazol- l-yl)-3- (trifluoromethyl)-benzenamine which is a key intermediate for the preparation of substituted pyrimidinylaminobenzamides of formula (11).
IN8588DEN2014 2005-06-09 2006-06-07 IN2014DN08588A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09
PCT/US2006/022154 WO2006135640A2 (en) 2005-06-09 2006-06-07 Process for the synthesis of organic compounds

Publications (1)

Publication Number Publication Date
IN2014DN08588A true IN2014DN08588A (en) 2015-07-10

Family

ID=37149980

Family Applications (2)

Application Number Title Priority Date Filing Date
IN8588DEN2014 IN2014DN08588A (en) 2005-06-09 2006-06-07
IN8578DEN2014 IN2014DN08578A (en) 2005-06-09 2006-06-07

Family Applications After (1)

Application Number Title Priority Date Filing Date
IN8578DEN2014 IN2014DN08578A (en) 2005-06-09 2006-06-07

Country Status (25)

Country Link
US (2) US7781597B2 (en)
EP (3) EP2292607B1 (en)
JP (2) JP5225078B2 (en)
KR (2) KR101283109B1 (en)
CN (6) CN102174019B (en)
AR (1) AR057056A1 (en)
AT (1) ATE540931T1 (en)
AU (3) AU2006258050B2 (en)
BR (1) BRPI0611683A2 (en)
CA (4) CA2886482C (en)
DK (2) DK2292607T3 (en)
ES (3) ES2380489T3 (en)
GT (1) GT200600202AA (en)
HU (1) HUE028024T2 (en)
IN (2) IN2014DN08588A (en)
JO (1) JO2758B1 (en)
MX (1) MX2007015609A (en)
MY (1) MY146795A (en)
PE (3) PE20100715A1 (en)
PL (3) PL2266961T3 (en)
PT (3) PT2292607E (en)
RU (1) RU2446162C2 (en)
SI (2) SI2292607T1 (en)
TW (1) TWI380981B (en)
WO (1) WO2006135640A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1930136B (en) 2004-03-05 2012-02-08 日产化学工业株式会社 Isoxazoline substituted benzamide compound and pest control agent
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (en) 2005-12-30 2013-10-21 Du Pont Isoxazolines for controlling invertebrate pests
US8623875B2 (en) 2007-06-13 2014-01-07 E.I. Du Pont De Nemours And Company Isoxazoline insecticides
TWI430995B (en) 2007-06-26 2014-03-21 Du Pont Naphthalene isoxazoline invertebrate pest control agents
EP2182945B1 (en) 2007-06-27 2015-08-05 E. I. du Pont de Nemours and Company Animal pest control method
TWI649303B (en) 2007-08-17 2019-02-01 杜邦股份有限公司 Compound and method for preparing 4-acetyl-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide
MX2010003557A (en) 2007-10-03 2010-04-12 Du Pont Naphthalene isoxazoline compounds for control of invertebrate pests.
TWI583664B (en) * 2008-04-09 2017-05-21 杜邦股份有限公司 Carbonyl compound and preparation method thereof
WO2010009402A2 (en) * 2008-07-17 2010-01-21 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
EP2530081A3 (en) 2008-11-05 2013-04-10 Teva Pharmaceutical Industries, Ltd. Nilotinib HCI crystalline forms
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
EP2576523B1 (en) 2010-05-27 2016-01-13 E. I. du Pont de Nemours and Company Crystalline form of 4-[5 - [3 -chloro-5 -(trifluoromethyl)phenyl] -4,5 -dihydro-5 -(trifluoromethyl)-3 - isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1- naphthalenecarboxamide
RS59420B1 (en) 2011-12-30 2019-11-29 Hanmi Pharmaceutical Co Ltd Thieno[3,2-d]pyrimidine derivatives having inhibitory activity for protein kinases
CN102592837B (en) * 2012-03-12 2014-01-15 河北师范大学 Method for preparing polyaniline electrode doped with tetrachloride metal quaternary ammonium salt for supercapacitor
CN103694176B (en) 2014-01-07 2015-02-18 苏州立新制药有限公司 Preparation method of nilotinib intermediate
CN104592122B (en) * 2014-12-09 2018-01-23 凯莱英医药集团（天津）股份有限公司 The preparation method of 3 (base of 4 methyl 1H imidazoles 1) 5 (trifluoromethyl) aniline
CN105985293B (en) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 The preparation method of AMN107 intermediate
EP3095782A1 (en) 2015-05-18 2016-11-23 Esteve Química, S.A. New method for preparing 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CN107201532B (en) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 The nitration method of aromatic compound
WO2019130254A1 (en) * 2018-01-01 2019-07-04 Laurus Labs Ltd An improved process for 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (en) * 2018-04-10 2020-01-21 江苏创诺制药有限公司 A crystal form of 3-(4-methyl-1H-imidazol-1-yl)-5-trifluoromethylaniline monohydrochloride and its application
AU2019285066B2 (en) 2018-06-15 2024-06-13 Handa Pharmaceuticals, Inc. Kinase inhibitor salts and compositions thereof
US11014945B2 (en) * 2019-04-06 2021-05-25 Trinapco, Inc. Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride
CN114751836B (en) * 2021-02-23 2024-05-31 四川青木制药有限公司 Synthesis method and intermediate of 3- (4-methyl-1H-imidazol-1-yl) -5- (trifluoromethyl) aniline
CN114853734A (en) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 A kind of preparation method of Nilotinib free base
CN116478319B (en) * 2022-11-07 2025-07-01 华北电力大学 Preparation method of an ionic covalent organic polymer and its application in adsorbing ReO4- in an alkaline environment
CN115626880B (en) * 2022-11-15 2023-11-14 常州大学 Synthesis method of 3-nitro-5-cyano benzotrifluoride
CN118108670B (en) * 2023-12-28 2025-07-01 江苏希迪制药有限公司 Purification method of nilotinib intermediate 3- (4-methyl-1H-imidazol-1-yl) -5- (trifluoromethyl) aniline
CN121517361A (en) * 2026-01-15 2026-02-13 湖南阿斯迪康药业有限公司 A method for synthesizing 1-arylimidazolium compounds based on bromobenzene compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (en) * 1982-04-09 1983-10-30 Алтайский политехнический институт Process for preparing imidazole derivatives
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
GR851296B (en) * 1984-05-29 1985-11-25 Pfizer
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (en) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals AMIDA COMPOSITE AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINASES, AND THE INSTRUCTIONS FOR USE
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
AR037647A1 (en) * 2002-05-29 2004-12-01 Novartis Ag USED DIARILUREA DERIVATIVES FOR THE TREATMENT OF DEPENDENT DISEASES OF THE PROTEIN KINase
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) * 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (en) * 2004-12-31 2007-04-04 孙飘扬 Amino-metadiazine compound and its salt, its preparation and pharmaceutical use
GT200600207A (en) * 2005-06-09 2007-01-15 Novartis Ag PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds

Also Published As

Publication number Publication date
JP2008546645A (en) 2008-12-25
PL1896426T3 (en) 2012-06-29
JP5225078B2 (en) 2013-07-03
AU2010241374B2 (en) 2011-11-03
TWI380981B (en) 2013-01-01
ES2380489T8 (en) 2012-06-22
EP2266961B1 (en) 2015-10-21
EP1896426A2 (en) 2008-03-12
KR101283109B1 (en) 2013-07-05
KR20080014010A (en) 2008-02-13
CN101189212B (en) 2011-05-18
CA2611280A1 (en) 2006-12-21
PE20100715A1 (en) 2010-10-25
EP1896426B1 (en) 2012-01-11
HUE028024T2 (en) 2016-11-28
CA2833394A1 (en) 2006-12-21
KR101249199B1 (en) 2013-04-03
ATE540931T1 (en) 2012-01-15
AU2006258050B2 (en) 2010-12-09
DK2266961T3 (en) 2016-01-25
ES2558696T3 (en) 2016-02-08
PE20100716A1 (en) 2010-10-25
US20080200692A1 (en) 2008-08-21
CA2886482C (en) 2017-09-05
CN102180796A (en) 2011-09-14
PL2292607T3 (en) 2014-09-30
CN102174020B (en) 2012-11-07
CN101189212A (en) 2008-05-28
CN102180836B (en) 2012-11-21
KR20120099028A (en) 2012-09-06
US7781597B2 (en) 2010-08-24
ES2465522T3 (en) 2014-06-06
CA2611280C (en) 2014-01-28
AU2006258050A1 (en) 2006-12-21
AR057056A1 (en) 2007-11-14
CN102174019B (en) 2013-02-13
US8008504B2 (en) 2011-08-30
WO2006135640A3 (en) 2007-08-02
RU2007148238A (en) 2009-07-20
SI2292607T1 (en) 2014-09-30
SI2266961T1 (en) 2016-02-29
CA2886482A1 (en) 2006-12-21
EP2292607A2 (en) 2011-03-09
CN102174021B (en) 2013-02-27
CA2942046A1 (en) 2006-12-21
CN102174019A (en) 2011-09-07
PT1896426E (en) 2012-04-12
CN102174020A (en) 2011-09-07
EP2292607A3 (en) 2011-04-27
PT2266961E (en) 2016-02-05
CN102180836A (en) 2011-09-14
IN2014DN08578A (en) 2015-07-10
MY146795A (en) 2012-09-28
PL2266961T3 (en) 2016-04-29
BRPI0611683A2 (en) 2010-09-28
ES2380489T3 (en) 2012-05-14
PE20070109A1 (en) 2007-04-02
JO2758B1 (en) 2014-03-15
EP2292607B1 (en) 2014-04-09
WO2006135640A2 (en) 2006-12-21
JP2013035855A (en) 2013-02-21
RU2446162C2 (en) 2012-03-27
DK2292607T3 (en) 2014-06-30
CA2833394C (en) 2016-03-29
AU2011201044A1 (en) 2011-03-31
US20100280257A1 (en) 2010-11-04
GT200600202AA (en) 2014-06-09
EP2266961A3 (en) 2011-07-27
EP2266961A2 (en) 2010-12-29
TW200716563A (en) 2007-05-01
CN102174021A (en) 2011-09-07
AU2010241374A1 (en) 2010-12-02
PT2292607E (en) 2014-06-24
MX2007015609A (en) 2008-02-25

Similar Documents

Publication Publication Date Title
IN2014DN08588A (en)
WO2009016462A3 (en) Substituted bicyclolactam compounds
UA93910C2 (en) urn:schemas-microsoft-com:office:smarttagsALKOXYALKYL-SUBSTITUTED CYCLIC KETOENOLS AND AGENT FOR PESTCONTROL
WO2007085895A3 (en) Fap inhibitors
TW200626559A (en) Anilino-pyrimidine analogs
WO2007105058A3 (en) Pyrazole compounds
WO2007106192A3 (en) Inhibitors of iap
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
MX2010002938A (en) (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1- carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating.
MX2007011023A (en) 2- (4-0x0-4h-quinaz0lin-3-yl) acetamides and their use as vasopressin v3 antagonists.
DK1696905T3 (en) Substituted 2-aminotetralines for the prophylactic treatment of Morbus Parkinson
WO2005087724A3 (en) Sulphonylpyrroles as hdac inhibitors
GB0510143D0 (en) Novel compounds A1
TW200624426A (en) BACE inhibitors
GB0521508D0 (en) Organic compounds
MY145788A (en) Antitumoral dihydropyran-2-one compounds
MY142105A (en) Leukotriene biosynthesis inhibitors
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
NZ595579A (en) 5-Difluoromethoxy-4-hydroxymethyl-1-methyl-3-trifluoromethyl-pyrazole / (5-(difluoromethoxy)-3-(trifluoromethyl)-1-methyl-1H-pyrazol-4-yl)methanol
WO2007062308A3 (en) Homo- and heterocyclic compounds suitable as cetp inhibitors
WO2007019191A3 (en) Thiazolopyrimidine kinase inhibitors
GB0412314D0 (en) Compounds
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
TW200745039A (en) Isotopically substituted pantoprazole
TW200710084A (en) Process for the synthesis of organic compounds